Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp
Bullboard Posts
User Avatar Image
(1)
•••
Comment by Ether8oreon Nov 05, 2019 7:43pm
69 Views
Post# 30313137

RE:RE:RE:RE:RE:RE:RE:Soaring price of insulin skyrockets

RE:RE:RE:RE:RE:RE:RE:Soaring price of insulin skyrockets
Redbaron2211 wrote: The patient can run and eat healthy all they want, one of the inclusion criteria was to be absent of stimulated c-peptide.   Finding it in the blood proves they are producing insulin.   In June/July we were waiting for Philip to update/release news at a conference.  Was great news you generally dont go to a conference to release bad news so I expect more progress and this time with out a PP clogging the pipes we might see more action.   Once again all the accumulation doesn't point to management hiding a bunch of funk data.  


elgin1 wrote:
Bioteck,

Remeber the patient had absoultey no c peptide at all.  They have c peptide now from insulin production via the pouch. Diet and exercise will not produce c peptide.  Give it a rest fearmongerer.

Bioteck you sure go out of your way to discredit the company. You spend so much time on it . This is personal for you.  Yiou are not an investor.  
 


Fully agree.

Eunice I would call it self moderated.  
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities